US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated

The summary for the US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated grant is detailed below. This summary states who is eligible for the grant, how much grant money will be awarded, current and past deadlines, Catalog of Federal Domestic Assistance (CFDA) numbers, and a sampling of similar government grants. Verify the accuracy of the data FederalGrants.com provides by visiting the webpage noted in the Link to Full Announcement section or by contacting the appropriate person listed as the Grant Announcement Contact. If any section is incomplete, please visit the website for the Centers for Disease Control and Prevention, which is the U.S. government agency offering this grant.
US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated: Influenza is an important cause of morbidity, mortality, and healthcare burden across all age groups.
Because influenza viruses are constantly changing and vaccines are reformulated every year, annual
estimates of the effectiveness of influenza vaccines in preventing influenza infection and its
associated complications are needed in order to evaluate the protection provided by annual,
nationwide vaccination programs.Each year in the United States, influenza viruses infect up to 20%
of the population and cause thousands of hospitalizations and deaths; influenza-associated
hospitalization rates are highest among older adults, persons ≥ 65 years old. Annual influenza
vaccination is the primary influenza prevention strategy and is recommended for all people ≥ 6
months of age in the U.S. Many studies have described the vaccine effectiveness (VE) of seasonal
and 2009 pandemic influenza vaccine formulations against laboratory-confirmed symptomatic and
medically-attended outpatient influenza illness (Treanor, 2012; Ohmit, 2014). In these and other
outpatient VE studies, older adults were underrepresented and data specific to the ≥ 65 year old age
group were limited. In contrast, hospitalization rates due to influenza are highest for older adults
compared to other age groups. However, published estimates of VE against laboratory-confirmed
influenza-associated hospitalization are uncommon. This funding opportunity announcement seeks
to support the development of a network of research institutions to estimate the annual effectiveness
of influenza vaccination in adult populations to prevent laboratory-confirmed influenza-associated
hospitalizations, especially among older adults.
Federal Grant Title: US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated
Federal Agency Name: Centers for Disease Control and Prevention
Grant Categories: Health
Type of Opportunity: Discretionary
Funding Opportunity Number: RFA-IP-15-002
Type of Funding: Cooperative Agreement
CFDA Numbers: 93.083, 93.185
CFDA Descriptions: Prevention of Disease, Disability, and Death through Immunization and Control of Respiratory and Related Diseases; Immunization Research, Demonstration, Public Information and Education_Training and Clinical Skills Improvement Projects
Current Application Deadline: Mar 3, 2015
Original Application Deadline: Mar 3, 2015
Posted Date: Dec 31, 2014
Creation Date: Dec 31, 2014
Archive Date: Apr 2, 2015
Total Program Funding: $11,600,000
Maximum Federal Grant Award: $3,000,000
Minimum Federal Grant Award: $275,000
Expected Number of Awards: 4
Cost Sharing or Matching: No
Applicants Eligible for this Grant
Others (see text field entitled "Additional Information on Eligibility" for clarification)
Additional Information on Eligibility
Eligibility Category: State governments
County governments
City or township governments
Special district governments
Independent school districts
Public and State controlled institutions of higher education
Native American tribal governments (Federally recognized)
Public housing authorities/Indian housing authorities
Native American tribal organizations (other than Federally recognized tribal
governments)
Nonprofits having a 501(c)(3) status with the IRS, other than institutions of
higher education
Private institutions of higher education
For profit organizations other than small businesses
Small businesses
The following types of Higher Education Institutions are always encouraged to apply for CDC support as
Public or Private Institutions of Higher Education:
Hispanic-serving Institutions
Historically Black Colleges and Universities (HBCUs)
Tribally Controlled Colleges and Universities (TCCUs)
Alaska Native and Native Hawaiian Serving Institutions
Nonprofits Other Than Institutions of Higher Education:
Nonprofits (Other than Institutions of Higher Education)
Governments:
Eligible Agencies of the Federal Government
U.S. Territory or Possession
Other:
Native American tribal organizations (other than Federally recognized tribal
governments)
Faith-based or Community-based Organizations
Regional Organizations
Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by
13 of 37
Bona Fide Agents: a Bona Fide Agent is an agency/organization identified by the state as eligible to submit an application under the state eligibility in lieu of a state application. If applying as a bona fide agent of a state or local
government, a legal, binding agreement from the state or local government as documentation of the status is required. Attach with "Other Attachment
Forms" when submitting via www.grants.gov.
Grant Announcement Contact
CDC/PGO [email protected] Phone 770-488-2700
[email protected]

Centers for Disease Control and Prevention 770-488-2756
Similar Government Grants
Collaborative research on influenza and other respiratory pathogens in South Africa
Public Health Epidemiology, Prevention and Control of Influenza and Other Respiratory Path...
Nationwide Cohort to Estimate Burden of Respiratory Viruses and Immunologic Response (Bloo...
Network of Community Cohorts for Monitoring Changes in Respiratory Virus Epidemiology (Pan...
Effectiveness of Empiric Antiviral Treatment for Hospitalized Community Acquired Pneumonia...
Epidemiology, Prevention, and Treatment of Influenza and Other Respiratory Infections in a...
Economic Studies of Immunization Policies and Practices
More Grants from the Centers for Disease Control and Prevention
Strengthening Public Health Systems and Services through National Partnerships to Improve ...
93.067
Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities o...
Technical Assistance to Support Comprehensive Combination HIV Prevention, Care and Treatme...
Strengthening Ebola rapid detection and response capacity through community based surveill...

FederalGrants.com is not endorsed by, or affiliated with, any government agency. Copyright ©2007-2024 FederalGrants.com